IOVS Circulation
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 1964;3:481-488.)
© 1964 by The Association for Research in Vision and Ophthalmology, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HARRIS, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HARRIS, J. E.

Symposium on Therapy: Complications and Management

Cardiovascular Renal agents as they Impinge on Ophthalmic Practice

JOHN E. HARRIS 1

1 Department of Ophthalmology, University of Minnesota Medical School, Minneapolis, Minn.

Of the large number of drugs which come under the classification of cardiovascular renal agents, only a few, the carbonic anhydrase inhibitors and the osmotic diuretics, have general usefulness in ophthalmic practice. However, a good portion of the patients the ophthalmologist may be treating may be taking other cardiovascular renal drugs for other physical ailments. The drugs of this group most likely to be encountered are the antiarterial hypertensives, the cardiac glycosides, and the various diuretics. Ophthalmologists must recognize the mode of action and side effects of these drugs, and the added toxicity which may be induced by the therapy which he applies.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1964 by the Association for Research in Vision and Ophthalmology